Gene silencing via genome editing
AssigneeSyngenta Crop Protection AG
InventorsJian LV, Xi CHEN, Kun YU, Dawei LIANG, Hongju ZHOU, Jianping XU
Life of this patent
Estimating the term…
Loading patent…
AssigneeSyngenta Crop Protection AG
InventorsJian LV, Xi CHEN, Kun YU, Dawei LIANG, Hongju ZHOU, Jianping XU
Estimating the term…
The present invention relates to methods and compositions for gene silencing by genome editing. In some embodiments, nucleases are provided selected from the group consisting of meganucleases (MNs), zinc-finger nucleases (ZFNs), transcription-activator like effector nucleases (TALENs), Cas9 nuclease, Cfp1 nuclease, dCas9-FokI, dCpf1-FokI, chimeric Cas9/Cpf1-cytidine deaminase, chimeric Cas9/Cpf1-adenine deaminase, chimeric FEN1-FokI, and Mega-TALs, a nickase Cas9 (nCas9), chimeric dCas9 non-FokI nuclease and dCpf1 non-FokI nuclease. Additionally, the present invention relates to methods and compositions for gene silencing by genome editing. Also provided are methods and compositions for rearranging a chromosome by genome editing.
1) A method of reducing expression a target gene comprised of:
9) A method of rearranging a chromosome by genome editing, comprising:
Dependencies are inferred from the claim text.